(Q36407477)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503860%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503860%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503860%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

M Faruk Kose

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503860%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Mutlu Meydanli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503860%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503860%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anticancer Therapy

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503860%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503860%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503860%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

437-443

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503860%20AND%20SRC:MED&resulttype=core&format=json

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

Gemcitabine and carboplatin in second-line ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

Remaining controversies in the upfront management of advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

21 January 2018

Recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

Is combination chemotherapy superior to single-agent chemotherapy in second-line treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

Treatment goals in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

Management of platinum-sensitive relapsed ovarian cancer, with particular reference to the International Collaboration in Ovarian Neoplasm-4/Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer-2.2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.437

21 January 2018

Identifiers

DOI

10.1586/14737140.6.3.437

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503860%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference